Nektar Therapeutics (NKTR)
1.285
-0.04
(-2.65%)
USD |
NASDAQ |
Apr 19, 12:58
Nektar Therapeutics 1 Year Total Returns (Daily): 42.33% for April 18, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 18, 2024 | 42.33% |
April 17, 2024 | 37.32% |
April 16, 2024 | 61.05% |
April 15, 2024 | 69.69% |
April 12, 2024 | 78.61% |
April 11, 2024 | 69.53% |
April 10, 2024 | 52.99% |
April 09, 2024 | 57.99% |
April 08, 2024 | 65.57% |
April 05, 2024 | 81.74% |
April 04, 2024 | 92.00% |
April 03, 2024 | 41.81% |
April 02, 2024 | 35.15% |
April 01, 2024 | 28.62% |
March 28, 2024 | 31.50% |
March 27, 2024 | 14.87% |
March 26, 2024 | 25.35% |
March 25, 2024 | 23.69% |
March 22, 2024 | 15.85% |
March 21, 2024 | 2.72% |
March 20, 2024 | -3.36% |
March 19, 2024 | -11.42% |
March 18, 2024 | -13.27% |
March 15, 2024 | -24.54% |
March 14, 2024 | -28.33% |
Date | Value |
---|---|
March 13, 2024 | -29.17% |
March 12, 2024 | -25.21% |
March 11, 2024 | -30.11% |
March 08, 2024 | -28.42% |
March 07, 2024 | -28.15% |
March 06, 2024 | -36.81% |
March 05, 2024 | -43.69% |
March 04, 2024 | -42.68% |
March 01, 2024 | -48.34% |
February 29, 2024 | -48.55% |
February 28, 2024 | -47.83% |
February 27, 2024 | -46.04% |
February 26, 2024 | -55.03% |
February 23, 2024 | -76.95% |
February 22, 2024 | -78.04% |
February 21, 2024 | -75.62% |
February 20, 2024 | -78.38% |
February 16, 2024 | -76.11% |
February 15, 2024 | -76.21% |
February 14, 2024 | -74.50% |
February 13, 2024 | -78.73% |
February 12, 2024 | -75.70% |
February 09, 2024 | -76.33% |
February 08, 2024 | -77.76% |
February 07, 2024 | -78.73% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-89.51%
Minimum
Nov 13 2023
92.00%
Maximum
Apr 04 2024
-47.38%
Average
-50.14%
Median
1 Year Total Returns (Daily) Benchmarks
Stereotaxis Inc | 33.15% |
Vanda Pharmaceuticals Inc | -20.22% |
Cara Therapeutics Inc | -83.80% |
Marinus Pharmaceuticals Inc | -82.83% |
DiaMedica Therapeutics Inc | 44.77% |